| Product Code: ETC11830158 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cell and Gene Supply Chain Services Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cell and Gene Supply Chain Services Market Revenues & Volume, 2021 & 2031F |
3.3 India Cell and Gene Supply Chain Services Market - Industry Life Cycle |
3.4 India Cell and Gene Supply Chain Services Market - Porter's Five Forces |
3.5 India Cell and Gene Supply Chain Services Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Cell and Gene Supply Chain Services Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 India Cell and Gene Supply Chain Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Cell and Gene Supply Chain Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Cell and Gene Supply Chain Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in biopharmaceutical research and development in India |
4.2.2 Growing demand for personalized medicine and advanced therapies |
4.2.3 Government initiatives to promote cell and gene therapy research and manufacturing in India |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy development and manufacturing |
4.3.2 Lack of skilled workforce and infrastructure for advanced therapy manufacturing |
4.3.3 Regulatory challenges and approval processes for cell and gene therapies in India |
5 India Cell and Gene Supply Chain Services Market Trends |
6 India Cell and Gene Supply Chain Services Market, By Types |
6.1 India Cell and Gene Supply Chain Services Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Cryogenic Storage Solutions, 2021 - 2031F |
6.1.4 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Logistics and Distribution, 2021 - 2031F |
6.1.5 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Quality Control Services, 2021 - 2031F |
6.1.6 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Supply Chain Software, 2021 - 2031F |
6.2 India Cell and Gene Supply Chain Services Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Cold Chain Management, 2021 - 2031F |
6.2.3 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Real-time Monitoring, 2021 - 2031F |
6.2.4 India Cell and Gene Supply Chain Services Market Revenues & Volume, By AI-driven Analytics, 2021 - 2031F |
6.2.5 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Blockchain Integration, 2021 - 2031F |
6.3 India Cell and Gene Supply Chain Services Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Biopharmaceutical Firms, 2021 - 2031F |
6.3.3 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.4 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Hospitals and Clinics, 2021 - 2031F |
6.3.5 India Cell and Gene Supply Chain Services Market Revenues & Volume, By CDMO and CROs, 2021 - 2031F |
6.4 India Cell and Gene Supply Chain Services Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Safe Storage of Cell Therapies, 2021 - 2031F |
6.4.3 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Secure Transportation of Samples, 2021 - 2031F |
6.4.4 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Ensuring Regulatory Compliance, 2021 - 2031F |
6.4.5 India Cell and Gene Supply Chain Services Market Revenues & Volume, By Tracking and Data Transparency, 2021 - 2031F |
7 India Cell and Gene Supply Chain Services Market Import-Export Trade Statistics |
7.1 India Cell and Gene Supply Chain Services Market Export to Major Countries |
7.2 India Cell and Gene Supply Chain Services Market Imports from Major Countries |
8 India Cell and Gene Supply Chain Services Market Key Performance Indicators |
8.1 Percentage increase in the number of clinical trials for cell and gene therapies in India |
8.2 Number of partnerships and collaborations between Indian companies and global players in the cell and gene therapy supply chain |
8.3 Investment trends in infrastructure development for cell and gene therapy manufacturing in India |
9 India Cell and Gene Supply Chain Services Market - Opportunity Assessment |
9.1 India Cell and Gene Supply Chain Services Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Cell and Gene Supply Chain Services Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 India Cell and Gene Supply Chain Services Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Cell and Gene Supply Chain Services Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Cell and Gene Supply Chain Services Market - Competitive Landscape |
10.1 India Cell and Gene Supply Chain Services Market Revenue Share, By Companies, 2024 |
10.2 India Cell and Gene Supply Chain Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here